BLAINJECTIONINJECTABLEPriority Review
Approved
Nov 1998
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
3
Data completeness
4/8 — Partial
Priority Review
THYROGEN (thyrotropin alfa) by Sanofi. Approved for differentiated thyroid cancer. First approved in 1998.
Drug data last refreshed 18h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
THYROGEN is a recombinant human thyroid-stimulating hormone (TSH) used to stimulate thyroid cancer cells for diagnostic imaging and ablation therapy in differentiated thyroid cancer patients. It is administered as an intramuscular injection and works by mimicking endogenous TSH to promote uptake of radioiodine in thyroid tissue. This biologic therapeutic eliminates the need for prolonged hypothyroidism during thyroid cancer monitoring.
$0.398MPart D
LOE ApproachingProduct approaching loss of exclusivity with modest Part D utilization signals need for defensive strategy and potential team rightsizing.
Mechanism of Action
Pharmacologic Class:
Thyroid Stimulating Hormone
Indications (1)
Clinical Trials (3)
A New Study to Follow-up Thyroid Cancer Patients Who Participated in a Previous Study, Which Compared the Success of Destruction of the Thyroid Remnant Using Standard Treatment or Thyrogen.
Started May 2006
61 enrolled
Differentiated Thyroid Cancer
Study Comparing Thyrogen Versus a Modified Release of Recombinant Human Thyroid Stimulating Hormone
Started Jun 2005
46 enrolled
Healthy
Comparison of the Safety and Successful Ablation of Thyroid Remnant in Post-thyroidectomized Euthyroid Patients (i.e. Patients Administered Thyrogen) Versus Hypothyroid Patients (no Thyrogen) Following 131I Administration
Started Dec 2001
63 enrolled
Thyroid Neoplasms
Worked on THYROGEN at Sanofi? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.